CATUG Biotechnology is a pharmaceutical manufacturing company that provides novel CRDMO services with a focus on mRNA, LNP, and high-quality plasmids. CATUG has comprehensive CDMO services for mRNA–LNP vaccines and therapeutics, including early R&D, process development, IND support, analytical testing, clinical trial development, and commercialization. The company integrates its plasmids manufacturing for a reliable supply of pDNA for mRNA products. Established in 2021, CATUG maintains four facilities and 100,000 square feet of GMP manufacturing space across Massachusetts, Switzerland, and China.